Skip to content

tirapazamine

DRUG18 trials

Sponsors

Stanford University, National Cancer Institute (NCI), SWOG Cancer Research Network, City of Hope Medical Center, Sanofi

Conditions

Alveolar Childhood RhabdomyosarcomaCarcinoma, HepatocellularCervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaCervical CancerCervical Squamous Cell CarcinomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood Rhabdomyosarcoma

Phase 1

Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
CompletedNCT00033410
California Cancer ConsortiumLung Cancer
Start: 2002-03-31Target: 30Updated: 2009-02-09
Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
CompletedNCT00005078
City of Hope Medical CenterUnspecified Adult Solid Tumor, Protocol Specific
Start: 2000-03-31End: 2012-07-31Updated: 2015-06-08
S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
CompletedNCT00006487
SWOG Cancer Research NetworkLung Cancer
Start: 2000-10-31End: 2004-07-31Updated: 2012-10-04
Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
CompletedNCT00003288
National Cancer Institute (NCI)Unspecified Childhood Solid Tumor, Protocol Specific
Start: 1998-08-31Updated: 2013-02-05
Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
CompletedNCT00098995
Peter MacCallum Cancer Centre, AustraliaCervical Cancer
Start: 2004-12-31End: 2010-01-31Target: 22Updated: 2013-06-26
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
RecruitingNCT02174549
Teclison Ltd.Gastrointestinal Cancer Metastatic, Hepatocellular Carcinoma, Neuroendocrine Tumors
Start: 2014-09-30End: 2025-12-31Target: 25Updated: 2024-11-22
Evaluate the Effect of Tirazamine on Primary Liver Cancer.
TerminatedNCT06848556
Zhejiang Raygene Pharmaceuticals Co., LtdHepato Cellular Carcinoma (HCC)
Start: 2021-05-14End: 2023-11-20Updated: 2025-02-27

Phase 2

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
CompletedNCT00025363
National Cancer Institute (NCI)Alveolar Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma +2
Start: 2001-11-30Updated: 2013-01-17
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
CompletedNCT00066742
National Cancer Institute (NCI)Limited Stage Small Cell Lung Cancer
Start: 2003-09-30End: 2009-08-31Updated: 2014-05-15
Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
CompletedNCT00020696
Gynecologic Oncology GroupOvarian Cancer, Primary Peritoneal Cavity Cancer
Start: 2001-06-30Updated: 2012-01-10
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
CompletedNCT00002774
Stanford UniversitySquamous Neck Carcinoma of the Head and Neck Cancer (SCCHN)
Start: 1996-06-30End: 2005-06-30Updated: 2014-06-20
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
CompletedNCT00003369
SWOG Cancer Research NetworkCervical Cancer
Start: 1998-08-31End: 2004-07-31Updated: 2012-06-14
TATE Versus TACE in Intermediate Stage HCC
TerminatedNCT03145558
Teclison Ltd.Carcinoma, Hepatocellular
Start: 2017-12-05End: 2024-06-30Updated: 2024-11-22
A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
RecruitingNCT06844357
Zhejiang Raygene Pharmaceuticals Co., LtdHCC
Start: 2025-03-27End: 2029-04-01Target: 300Updated: 2025-04-06

Phase 3